Search - tctmd.com

Displaying 141 - 160 of 170

Sort: Relevancy | Date

Presentation THT 2024

Early Experience With the Supira Microaxial Flow Pump

Presenter: Azeem Latib

March 05, 2024

Presentation THT 2024

The Impella Portfolio of Devices for Cardiogenic Shock (Left-Sided Support)

Presenter: Justin Fried

March 05, 2024

Presentation THT 2024

Istraoxime for Cardiogenic Shock

Presenter: Gad Cotter

March 05, 2024

Presentation THT 2024

Potential Benefits of Decreasing HR: Adjuntive Therapies to Pumps

Presenter: Hidetaka Morita

March 05, 2024

Presentation THT 2024

Cardiogenic Shock: The Urgent Need for Innovation in Devices and Technologies for Shock

Presenter: Navin K. Kapur

March 05, 2024

Presentation THT 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT 2024

Cardiogenic Shock in Stress Induced Cardiomyopathy Complicated by Left Ventricular Outflow Obstruction: Hemodynamic-Tailored Management

Presenter: Mary Quien

March 05, 2024

Presentation THT Abstracts 2024

Association Between Inpatient Percutaneous Coronary Intervention Volume and Thirty-Day Readmissions After Acute†Myocardial Infarction- Cardiogenic Shock

Presenter: Kannu Bansal

March 04, 2024

Presentation THT Abstracts 2024

Impact of Cumulative Vasopressor and Inotrope Medications on Outcomes in Cardiogenic Shock: A Cardiogenic Shock Working Group Report

Presenter: Saraschandra Vallabhajosyula

March 04, 2024

Presentation THT Abstracts 2024

Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock

Presenter: McKenzie Sicke

March 04, 2024

Presentation THT Abstracts 2024

The Clinical Effectiveness of Pulmonary Artery Catheter in Patients with Cardiogenic Shock

Presenter: Atsuyuki Watanabe

March 04, 2024

Presentation THT Abstracts 2024

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

Presentation THT Abstracts 2024

ImpellaÆ Use Improves Hemodynamics for Cardiogenic Shock from Ventricular Septal Defect (VSD)

Presenter: Brent Medoff

March 04, 2024

Presentation THT Abstracts 2024

Impact of Cardiogenic Shock Progression on Outcomes: SCAI B is Bad 2013 A Cardiogenic Shock Working Group Report

Presenter: Van-Khue Ton

March 04, 2024

Presentation THT Abstracts 2024

Temporal Trends of Vasopressor and Inotrope Use in Cardiogenic Shock: A Cardiogenic Shock Working Group Report

Presenter: Saraschandra Vallabhajosyula

March 04, 2024

Presentation THT Abstracts 2024

Assessment of patients with cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation upgrade from Impella 5.5 univentricular support

Presenter: James Schurr

March 04, 2024

Presentation THT 2024

Cardiogenic Shock: The Case for Feasibility and Recovery

Presenter: Aasim Afzal

March 04, 2024

Presentation THT 2024

Achieving Heart Recovery in HF with Cardiogenic Shock

Presenter: Debbie Rinde-Hoffman

March 04, 2024

Presentation THT 2024

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

News Opinion Off Script

Passion, Persistence, and Generosity: Remembering Alain Cribier

Martin B. Leon, MD

February 27, 2024

Advertisement

Early Experience With the Supira Microaxial Flow Pump

The Impella Portfolio of Devices for Cardiogenic Shock (Left-Sided Support)

Istraoxime for Cardiogenic Shock

Potential Benefits of Decreasing HR: Adjuntive Therapies to Pumps

Cardiogenic Shock: The Urgent Need for Innovation in Devices and Technologies for Shock

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Cardiogenic Shock in Stress Induced Cardiomyopathy Complicated by Left Ventricular Outflow Obstruction: Hemodynamic-Tailored Management

Association Between Inpatient Percutaneous Coronary Intervention Volume and Thirty-Day Readmissions After Acute†Myocardial Infarction- Cardiogenic Shock

Impact of Cumulative Vasopressor and Inotrope Medications on Outcomes in Cardiogenic Shock: A Cardiogenic Shock Working Group Report

Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock

The Clinical Effectiveness of Pulmonary Artery Catheter in Patients with Cardiogenic Shock

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

ImpellaÆ Use Improves Hemodynamics for Cardiogenic Shock from Ventricular Septal Defect (VSD)

Impact of Cardiogenic Shock Progression on Outcomes: SCAI B is Bad 2013 A Cardiogenic Shock Working Group Report

Temporal Trends of Vasopressor and Inotrope Use in Cardiogenic Shock: A Cardiogenic Shock Working Group Report

Assessment of patients with cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation upgrade from Impella 5.5 univentricular support

Cardiogenic Shock: The Case for Feasibility and Recovery

Achieving Heart Recovery in HF with Cardiogenic Shock

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Passion, Persistence, and Generosity: Remembering Alain Cribier

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content